EGFR and neoplasm: In cancer, for example, the expression of any one biomarker, such as HER2 or EGFR, can easily span a broad range between different tumor subtypes, or even within metastatic sites, making searching for broadly applicable biomarkers for diagnosis or treatment challenging [195].